Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 135

1.

VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.

Johnston EW, Bonet-Carne E, Ferizi U, Yvernault B, Pye H, Patel D, Clemente J, Piga W, Heavey S, Sidhu HS, Giganti F, O'Callaghan J, Brizmohun Appayya M, Grey A, Saborowska A, Ourselin S, Hawkes D, Moore CM, Emberton M, Ahmed HU, Whitaker H, Rodriguez-Justo M, Freeman A, Atkinson D, Alexander D, Panagiotaki E, Punwani S.

Radiology. 2019 May;291(2):391-397. doi: 10.1148/radiol.2019181749. Epub 2019 Apr 2.

PMID:
30938627
2.

The contribution of multiparametric pelvic & whole body MR to interpretation of 18F-fluoromethylcholine or 68Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure following radical prostatectomy.

Metser U, Chua SS, Ho B, Punwani S, Johnston E, Pouliot F, Tau N, Hawsawy A, Anconina R, Bauman G, Hicks RJ, Weickhardt A, Davis ID, Pond G, Scott A, Tunariu N, Sidhu H, Emmett LM.

J Nucl Med. 2019 Mar 22. pii: jnumed.118.225185. doi: 10.2967/jnumed.118.225185. [Epub ahead of print]

PMID:
30902875
3.

VERDICT MRI validation in fresh and fixed prostate specimens using patient-specific moulds for histological and MR alignment.

Bailey C, Bourne RM, Siow B, Johnston EW, Brizmohun Appayya M, Pye H, Heavey S, Mertzanidou T, Whitaker H, Freeman A, Patel D, Shaw GL, Sridhar A, Hawkes DJ, Punwani S, Alexander DC, Panagiotaki E.

NMR Biomed. 2019 May;32(5):e4073. doi: 10.1002/nbm.4073. Epub 2019 Feb 19.

PMID:
30779863
4.

Optimization and Repeatability of Multipool Chemical Exchange Saturation Transfer MRI of the Prostate at 3.0‚ÄČT.

Evans VS, Torrealdea F, Rega M, Brizmohun Appayya M, Latifoltojar A, Sidhu H, Kim M, Kujawa A, Punwani S, Golay X, Atkinson D.

J Magn Reson Imaging. 2019 Feb 15. doi: 10.1002/jmri.26690. [Epub ahead of print]

PMID:
30770603
5.

Prostate cancer treated with irreversible electroporation: MRI-based volumetric analysis and oncological outcome.

Giganti F, Stabile A, Giona S, Marenco J, Orczyk C, Moore CM, Allen C, Kirkham A, Emberton M, Punwani S.

Magn Reson Imaging. 2019 May;58:143-147. doi: 10.1016/j.mri.2019.02.003. Epub 2019 Feb 12.

PMID:
30768957
6.

Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer.

Stabile A, Orczyk C, Hosking-Jervis F, Giganti F, Arya M, Hindley RG, Dickinson L, Allen C, Punwani S, Jameson C, Freeman A, McCartan N, Montorsi F, Briganti A, Ahmed HU, Emberton M, Moore CM.

BJU Int. 2019 Feb 12. doi: 10.1111/bju.14710. [Epub ahead of print]

PMID:
30753756
7.

Association of bone mineral density and fat fraction with magnetic susceptibility in inflamed trabecular bone.

Bray TJP, Karsa A, Bainbridge A, Sakai N, Punwani S, Hall-Craggs MA, Shmueli K.

Magn Reson Med. 2019 May;81(5):3094-3107. doi: 10.1002/mrm.27634. Epub 2019 Jan 7.

PMID:
30615213
8.

Simplified Luminal Water Imaging for the Detection of Prostate Cancer From Multiecho T2 MR Images.

Devine W, Giganti F, Johnston EW, Sidhu HS, Panagiotaki E, Punwani S, Alexander DC, Atkinson D.

J Magn Reson Imaging. 2018 Dec 19. doi: 10.1002/jmri.26608. [Epub ahead of print]

PMID:
30566264
9.

The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk Stratification.

Hamid S, Donaldson IA, Hu Y, Rodell R, Villarini B, Bonmati E, Tranter P, Punwani S, Sidhu HS, Willis S, van der Meulen J, Hawkes D, McCartan N, Potyka I, Williams NR, Brew-Graves C, Freeman A, Moore CM, Barratt D, Emberton M, Ahmed HU.

Eur Urol. 2019 May;75(5):733-740. doi: 10.1016/j.eururo.2018.08.007. Epub 2018 Dec 6.

10.

Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: diagnostic accuracy and interobserver agreement for nodal and metastatic staging.

Johnston EW, Latifoltojar A, Sidhu HS, Ramachandran N, Sokolska M, Bainbridge A, Moore C, Ahmed HU, Punwani S.

Eur Radiol. 2018 Dec 5. doi: 10.1007/s00330-018-5813-4. [Epub ahead of print]

11.

GAS: A genetic atlas selection strategy in multi-atlas segmentation framework.

Antonelli M, Cardoso MJ, Johnston EW, Appayya MB, Presles B, Modat M, Punwani S, Ourselin S.

Med Image Anal. 2019 Feb;52:97-108. doi: 10.1016/j.media.2018.11.007. Epub 2018 Nov 19.

PMID:
30476698
12.

Multi-parametric MRI zone-specific diagnostic model performance compared with experienced radiologists for detection of prostate cancer.

Dikaios N, Giganti F, Sidhu HS, Johnston EW, Appayya MB, Simmons L, Freeman A, Ahmed HU, Atkinson D, Punwani S.

Eur Radiol. 2018 Nov 19. doi: 10.1007/s00330-018-5799-y. [Epub ahead of print]

13.

A Prospective, Multi-site, International Comparison of F-18 fluoro-methyl-choline, multi-parametric magnetic resonance and Ga-68 HBED-CC (PSMA-11) in men with High-Risk Features and Biochemical Failure after Radical Prostatectomy: Clinical Performance and Patient Outcomes.

Emmett L, Metser U, Bauman G, Hicks RJ, Weickhardt A, Davis ID, Punwani S, Pond GR, Chua SS, Ho B, Johnston E, Pouliot F, Scott A.

J Nucl Med. 2018 Nov 15. pii: jnumed.118.220103. doi: 10.2967/jnumed.118.220103. [Epub ahead of print]

PMID:
30442757
14.

VERDICT-AMICO: Ultrafast fitting algorithm for non-invasive prostate microstructure characterization.

Bonet-Carne E, Johnston E, Daducci A, Jacobs JG, Freeman A, Atkinson D, Hawkes DJ, Punwani S, Alexander DC, Panagiotaki E.

NMR Biomed. 2019 Jan;32(1):e4019. doi: 10.1002/nbm.4019. Epub 2018 Oct 31.

PMID:
30378195
15.

Prostate cancer diagnostic pathway: Is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UK.

Bass EJ, Freeman A, Jameson C, Punwani S, Moore CM, Arya M, Emberton M, Ahmed HU.

BMJ Open. 2018 Oct 24;8(10):e024941. doi: 10.1136/bmjopen-2018-024941.

16.

Sequential prostate MRI reporting in men on active surveillance: initial experience of a dedicated PRECISE software program.

Giganti F, Allen C, Piper JW, Mirando D, Stabile A, Punwani S, Kirkham A, Emberton M, Moore CM.

Magn Reson Imaging. 2019 Apr;57:34-39. doi: 10.1016/j.mri.2018.10.013. Epub 2018 Oct 20.

PMID:
30352271
17.

The effect of low resolution and coverage on the accuracy of susceptibility mapping.

Karsa A, Punwani S, Shmueli K.

Magn Reson Med. 2019 Mar;81(3):1833-1848. doi: 10.1002/mrm.27542. Epub 2018 Oct 19.

PMID:
30338864
18.

A Dedicated Prostate MRI Teaching Course Improves the Ability of the Urologist to Interpret Clinically Significant Prostate Cancer on Multiparametric MRI.

Kasivisvanathan V, Ambrosi A, Giganti F, Chau E, Kirkham A, Punwani S, Allen C, Emberton M, Moore CM.

Eur Urol. 2019 Jan;75(1):203-204. doi: 10.1016/j.eururo.2018.09.033. Epub 2018 Oct 14. No abstract available.

PMID:
30327275
19.

Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.

Olivier J, Stavrinides V, Kay J, Freeman A, Pye H, Ahmed Z, Carmona Echeverria L, Heavey S, Simmons LAM, Kanthabalan A, Arya M, Briggs T, Barratt D, Charman SC, Gelister J, Hawkes D, Hu Y, Jameson C, McCartan N, Punwani S, van der Muelen J, Moore C, Emberton M, Ahmed HU, Whitaker HC.

Prostate. 2018 Dec;78(16):1229-1237. doi: 10.1002/pros.23698. Epub 2018 Aug 2.

PMID:
30073682
20.

The natural history of prostate cancer on MRI: lessons from an active surveillance cohort.

Giganti F, Moore CM, Punwani S, Allen C, Emberton M, Kirkham A.

Prostate Cancer Prostatic Dis. 2018 Nov;21(4):556-563. doi: 10.1038/s41391-018-0058-5. Epub 2018 Jul 23.

PMID:
30038388

Supplemental Content

Loading ...
Support Center